Suicide by hanging under the influence of ketamine and ethanol

Forensic Science International

Volumn 202, Issue 1-3, 2010, Pages

  Dinis Oliveira, Ricardo Jorge ^a,b,c   Carvalho, Félix ^c   Duarte, José Alberto ^c   Dias, Ricardo ^d   Magalhães, Teresa ^a,c,d,e   Santos, Agostinho ^a,d,e  

^a University of Porto   (Portugal)

^b Polytechnic Health Institute of North   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d North Branch National Institute of Legal Medicine IP   (Portugal)

^e Portuguese Science and Technology Foundation   (Portugal)

Author keywords

Asphyxiation; Hanging; Intoxication; Ketamine

Indexed keywords

ALCOHOL; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADULT; ALCOHOL ABUSE; ALCOHOL BLOOD LEVEL; ALCOHOLISM; ARTICLE; ASPHYXIA; AUTOPSY; CASE REPORT; DRUG BLOOD LEVEL; FATALITY; FORENSIC TOXICOLOGY; HANGING; HUMAN; INTOXICATION; MALE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SUICIDAL BEHAVIOR; SUICIDE; VICTIM; WORKPLACE;

EID: 79955101917     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2010.04.047     Document Type: Article

References (37)

1. Schneider B. Substance use disorders and risk for completed suicide. Archives of Suicide Research 2009, 13:303-316.
2. Schneider B., Kolves K., Blettner M., Wetterling T., Schnabel A., Varnik A. Substance use disorders as risk factors for suicide in an Eastern and a Central European city (Tallinn and Frankfurt/Main). Psychiatry Research 2009, 165:263-272.
3. Machata G. The advantages of automated blood alcohol determination by head space analysis. Zeitschrift fur Rechtsmedizin 1975, 75:229-234.
4. DrugScope, Highlights concerns over trends in ketamine use, (accessed April 18, 2010) (2009). http://www.drugscope.org.uk/ourwork/pressoffice/pressreleases/DS_concern_ketamine_trends.
5. Moore K.A., Kilbane E.M., Jones R., Kunsman G.W., Levine B., Smith M. Tissue distribution of ketamine in a mixed drug fatality. Journal of Forensic Sciences 1997, 42:1183-1185.
6. Lalonde B.R., Wallage H.R. Post mortem blood ketamine distribution in two fatalities. Journal of Analytical Toxicology 2004, 28:71-74.
7. McCarthy D.A., Chen G., Kaump D.H., Ensor C. General anesthetic and other pharmacological properties of 2-(O-chlorophenyl)-2-methylamino cyclohexanone HCl (Ci-58l). The Journal of New Drugs 1965, 28:21-33.
8. Felser J.M., Orban D.J. Dystonic reaction after ketamine abuse. Annals of Emergency Medicine 1982, 11:673-675.
9. Lin C., Durieux M.E. Ketamine and kids: an update. Paediatric Anaesthesia 2005, 15:91-97.
10. Restall J., Tully A.M., Ward P.J., Kidd A.G. Total intravenous anaesthesia for military surgery. A technique using ketamine, midazolam and vecuronium. Anaesthesia 1988, 43:46-49.
11. Wright M. Pharmacologic effects of ketamine and its use in veterinary medicine. Journal of the American Veterinary Medical Association 1982, 180:1462-1471.
12. Corssen G., Domino E.F. Dissociative anesthesia: further pharmacologic studies and first clinical experience with the phencyclidine derivative CI-581. Anaesthesia and Analgesia 1966, 45:29-40.
13. Jansen K.L. Non-medical use of ketamine. British Medical Journal (Clinical Research Edition) 1993, 306:601-602.
14. Jansen K.L. A review of the nonmedical use of ketamine: use, users and consequences. Journal of Psychoactive Drugs 2000, 32:419-433.
15. Jansen K.L., Darracot-Cankovic R. The nonmedical use of ketamine, part two: a review of problem use and dependence. Journal of Psychoactive Drugs 2001, 33:151-158.
16. Moore K.A., Sklerov J., Levine B., Jacobs A.J. Urine concentrations of ketamine and norketamine following illegal consumption. Journal of Analytical Toxicology 2001, 25:583-588.
17. Kim E.M., Lee J.S., Choi S.K., Lim M.A., Chung H.S. Analysis of ketamine and norketamine in urine by automatic solid-phase extraction (SPE) and positive ion chemical ionization-gas chromatography-mass spectrometry (PCI-GC-MS). Forensic Science International 2008, 174:197-202.
18. Ahmed S.N., Petchkovsky L. Abuse of ketamine. British Journal of Psychiatry 1980, 137:303.
19. Morgan C.J., Riccelli M., Maitland C.H., Curran H.V. Long-term effects of ketamine: evidence for a persisting impairment of source memory in recreational users. Drug and Alcohol Dependence 2004, 75:301-308.
20. Stefanovic A., Brandner B., Klaassen E., Cregg R., Nagaratnam M., Bromley L.M., Das R.K., Rossell S.L., Morgan C.J., Curran H.V. Acute and chronic effects of ketamine on semantic priming: modeling schizophrenia?. Journal of Clinical Psychopharmacology 2009, 29:124-133.
21. Wu C.H., Huang M.H., Wang S.M., Lin C.C., Liu R.H. Gas chromatography-mass spectrometry analysis of ketamine and its metabolites-a comparative study on the utilization of different derivatization groups. Journal of Chromatography 2007, 1157:336-351.
22. Gill J.R., Stajic M. Ketamine in non-hospital and hospital deaths in New York City. Journal of Forensic Sciences 2000, 45:655-658.
23. Anis N.A., Berry S.C., Burton N.R., Lodge D. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. British Journal of Pharmacology 1983, 79:565-575.
24. MacDonald J.F., Bartlett M.C., Mody I., Pahapill P., Reynolds J.N., Salter M.W., Schneiderman J.H., Pennefather P.S. Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones. The Journal of Physiology 1991, 432:483-508.
25. Lovinger D.M., White G., Weight F.F. Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science (New York, NY) 1989, 243:1721-1724.
26. Wright J.M., Peoples R.W., Weight F.F. Single-channel and whole-cell analysis of ethanol inhibition of NMDA-activated currents in cultured mouse cortical and hippocampal neurons. Brain Research 1996, 738:249-256.
27. Krystal J.H., Petrakis I.L., Webb E., Cooney N.L., Karper L.P., Namanworth S., Stetson P., Trevisan L.A., Charney D.S. Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics. Archives of General Psychiatry 1998, 55:354-360.
28. Krystal J.H., Petrakis I.L., Krupitsky E., Schutz C., Trevisan L., D'Souza D.C. MDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy. Annals of the New York Academy of Sciences 2003, 1003:176-184.
29. Krystal J.H., Petrakis I.L., Limoncelli D., Webb E., Gueorgueva R., D'Souza D.C., Boutros N.N., Trevisan L., Charney D.S. Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients. Neuropsychopharmacology 2003, 28:2020-2028.
30. Phelps L.E., Brutsche N., Moral J.R., Luckenbaugh D.A., Manji H.K., Zarate C.A. Family history of alcohol dependence and initial antidepressant response to an N-methyl-d-aspartate antagonist. Biological Psychiatry 2009, 65:181-184.
31. Crabbe J.C., Merrill C.D., Belknap J.K. Effects of convulsants on handling-induced convulsions in mice selected for ethanol withdrawal severity. Brain Research 1991, 550:1-6.
32. Gulya K., Grant K.A., Valverius P., Hoffman P.L., Tabakoff B. Brain regional specificity and time-course of changes in the NMDA receptor-ionophore complex during ethanol withdrawal. Brain Research 1991, 547:129-134.
33. Nagy J. Renaissance of NMDA receptor antagonists: do they have a role in the pharmacotherapy for alcoholism?. Drugs 2004, 7:339-350.
34. Roberto M., Bajo M., Crawford E., Madamba S.G., Siggins G.R. Chronic ethanol exposure and protracted abstinence alter NMDA receptors in central amygdala. Neuropsychopharmacology 2006, 31:988-996.
35. Michaelis E.K., Freed W.J., Galton N., Foye J., Michaelis M.L., Phillips I., Kleinman J.E. Glutamate receptor changes in brain synaptic membranes from human alcoholics. Neurochemical Research 1990, 15:1055-1063.
36. Michaelis E.K., Michaelis M.L., Freed W.J., Foye J. Glutamate receptor changes in brain synaptic membranes during chronic alcohol intake. Alcohol and Alcoholism (Oxford, Oxfordshire) 1993, 2:377-381.
37. Dickerson D., Pittman B., Ralevski E., Perrino A., Limoncelli D., Edgecombe J., Acampora G., Krystal J.H., Petrakis I. Ethanol-like effects of thiopental and ketamine in healthy humans. Journal of Psychopharmacology (Oxford, England) 2010, 24:203-211.